4 days Ago By Defense World Staff
Wells Fargo & Company MN lowered its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 20.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 338,971 shares of the company’s stock after selling 88,977 shares during the period.
Wells Fargo & Company MN’s holdings in BlackRock Health Sciences Trust were worth $12,857,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Raymond James Financial Inc.
bought a new stake in shares of BlackRock Health Sciences Trust in the 4th quarter worth approximately $3,250,000. Wolverine Asset Management LLC increased its position in BlackRock Health Sciences Trust by 29.1% in the fourth quarter.
Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock worth $4,191,000 after buying an additional 24,928 shares during the period. AlphaStar Capital Management LLC bought a new stake in BlackRock Health Sciences Trust in the fourth quarter valued at $878,000. Hara Capital LLC acquired a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at $832,000.
Finally, Janney Montgomery Scott LLC grew its position in shares of BlackRock Health Sciences Trust by 40.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after acquiring an additional 9,455 shares during the last quarter.
BlackRock Health Sciences Trust Stock Down 0.4 %BME stock opened at $36.13 on Wednesday.
The firm’s 50-day simple moving average is $38.76 and its 200 day simple moving average is $39.47.
BlackRock Health Sciences Trust has a fifty-two week low of $34.18 and a fifty-two week high of $42.64.
BlackRock Health Sciences Trust Announces DividendThe firm also recently declared a monthly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Tuesday, April 15th will be issued a dividend of $0.2621 per share.
The ex-dividend date is Tuesday, April 15th. This represents a $3.15 dividend on an annualized basis and a dividend yield of 8.
71%. About BlackRock Health Sciences Trust (Free Report)BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States.
The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.Featured ArticlesFive stocks we like better than BlackRock Health Sciences TrustWhat is a Special Dividend?Beware of BigBear.ai: Insiders Are Selling—Should You?Mastering Discipline: Overcoming Emotional Challenges In TradingCrowdStrike Stock is a Buy as Cyberthreat Environment ExpandsHow to Know Which Cryptocurrency to Buy: A Guide for InvestorsCongress! Who Traded What During the Tariff-Induced Meltdown Want to see what other hedge funds are holding BME? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report)..
